Table Of Contents

1. Introduction 28
1.1. Objectives Of The Study 28
1.2. Market Definition 28
1.3. Overview Of Global Microfluidics Market 28
1.4. Currency And Pricing 29
1.5. Limitation 29
1.6. Markets Covered 30
2. Market Segmentation 32
2.1. Markets Covered 32
2.2. Geographic Scope 33
2.3. Years Considered For The Study 34
2.4. Currency And Pricing 34
2.5. Research Methodology 35
2.6. Primary Interviews With Key Opinion Leaders 38
2.7. Secondary Sources 39
2.8. Assumptions 39
3. Market Overview 40
3.1. Drivers 42
3.1.1. Increased Demand Of Poc Testing 42
3.1.2. Wide Range Of Applications In Different Sectors 43
3.1.3. Benefits Associated With Incorporation Of Microfluidics 44
3.1.4. High Return On Investments 45
3.2. Restraints 47
3.2.1. Complexity In Incorporating Microfluidics Technology In The Existing Procedures 47
?
3.3. Opportunities 48
3.3.1. Lucrative Opportunities In Emerging Region 48
3.3.2. Rise In The Drug Discovery Research 50
3.4. Challenges 50
3.4.1. Lack Of Visibility In The Market 50
4. Executive Summary 51
5. Premium Insights 54
6. Global Microfluidics Market, By Component 57
6.1. Overview 58
6.2. Microfluidics Chips 59
6.3. Micropumps 61
6.4. Microneedles 63
6.5. Others 65
7. Global Microfluidics Market, By Material 67
7.1. Overview 68
7.2. Polymer 69
7.3. Glass 71
7.4. Silicon 72
7.5. Others 73
?
8. Global Microfluidics Market, By Sector 74
8.1. Overview 75
8.2. Healthcare 77
8.2.1. Poc Diagnostics 79
8.2.2. Cell Analysis 79
8.2.3. Drug Discovery 79
8.2.4. Immunoassays 80
8.2.5. Genotyping & Sequencing 80
8.2.6. Microarray Analysis 80
8.2.7. In-Vitro Diagnostics 81
8.2.8. Biomarker Analysis 81
8.2.9. Others 81
8.3. Industrial 82
8.3.1. Biotechnology 83
8.3.2. Energy 84
8.3.3. Nutraceuticals & Food 84
8.3.4. Cosmetics 84
8.3.5. Chemical 85
9. Global Microfluidics Market, By End User 86
9.1. Overview 87
9.2. Hospitals 89
9.3. Research Laboratories & Academia 90
9.4. Industrial R&D 91
?
10. Global Microfluidics Market, By Geography 92
10.1. Overview 93
10.2. North America 100
10.2.1. U.S. 110
10.2.2. Canada 114
10.2.3. Mexico 118
10.3. Europe 122
10.3.1. Germany 133
10.3.2. France 138
10.3.3. U.K. 142
10.3.4. Italy 146
10.3.5. Spain 150
10.3.6. Netherlands 154
10.3.7. Switzerland 159
10.3.8. Belgium 163
10.3.9. Russia 167
10.3.10. Turkey 171
10.3.11. Rest Of Europe 175
10.4. Asia Pacific 176
10.4.1. Japan 187
10.4.2. China 191
10.4.3. India 195
10.4.4. South Korea 199
10.4.5. Australia 203
10.4.6. Singapore 207
10.4.7. Thailand 211
10.4.8. Malaysia 215
10.4.9. Indonesia 219
10.4.10. Philippines 224
10.4.11. Rest Of Asia Pacific 228
10.5. South America 229
10.5.1. Brazil 239
10.5.2. Rest Of South America 243
10.6. Middle East And Africa 244
10.6.1. South Africa 254
10.6.2. Rest Of Middle East And Africa 258
11. Global Microfluidics Market, Company Landscape 259
11.1. Company Share Analysis; Global 259
11.2. Company Share Analysis; North America 260
11.3. Company Share Analysis; Europe 261
11.4. Company Share Analysis; Asia Pacific 262
12. Company Profiles 263
12.1. Perkinelmer Inc. 263
12.1.1. Company Overview 263
12.1.2. Perkinelmer Inc.; Revenue Analysis 264
12.1.3. Product Portfolio 265
12.1.4. Recent Developments 267
12.2. Dolomite Microfluidics 268
12.2.1. Company Overview 268
12.2.2. Dolomite Microfluidics; Company Snapshot 268
12.2.3. Product Portfolio 269
12.2.4. Recent Developments 271
12.3. Microfluidics 273
12.3.1. Company Overview 273
12.3.2. Microfluidics; Company Snapshot 273
12.3.3. Product Portfolio 274
12.3.4. Recent Developments 275
12.4. Abaxis 276
12.4.1. Company Overview 276
12.4.2. Abaxis; Revenue Analysis 276
12.4.3. Product Portfolio 277
12.4.4. Recent Developments 277
12.5. Abbott 278
12.5.1. Company Overview 278
12.5.2. Abbott; Revenue Analysis 278
12.5.3. Product Portfolio 279
12.5.4. Recent Developments 279
12.6. Agilent Technologies 280
12.6.1. Company Overview 280
12.6.2. Agilent Technologies;Revenue Analysis 280
12.6.3. Product Portfolio 281
12.6.4. Recent Developments 281
12.7. Akonni Biosystems Inc. 282
12.7.1. Company Overview 282
12.7.2. Akonni Biosystems, Inc.; Company Snapshot 282
12.7.3. Product Portfolio 283
12.7.4. Recent Developments 283
12.8. Aviva Biosciences 284
12.8.1. Company Overview 284
12.8.2. Aviva Biosciences; Company Snapshot 284
12.8.3. Product Portfolio 284
12.8.4. Recent Developments 284
12.9. Bio-Rad Laboratories Inc. 285
12.9.1. Company Overview 285
12.9.2. Bio-Rad Laboratories, Inc.; Revenue Analysis 285
12.9.3. Product Portfolio 286
12.9.4. Recent Developments 286
12.10. Cepheid 287
12.10.1. Company Overview 287
12.10.2. Cepheid; Company Snapshot 287
12.10.3. Product Portfolio 287
12.10.4. Recent Developments 287
12.11. Fluxion Bioscience 288
12.11.1. Company Overview 288
12.11.2. Fluxion Bioscience; Company Snapshot 288
12.11.3. Product Portfolio 289
12.11.4. Recent Developments 289
12.12. Hewlett-Packard 290
12.12.1. Company Overview 290
12.12.2. Hp Inc.; Revenue Analysis 290
12.12.3. Product Portfolio 291
12.12.4. Recent Developments 291
12.13. Illumina Inc. 292
12.13.1. Company Overview 292
12.13.2. Illumina, Inc.;Revenue Analysis 292
12.13.3. Product Portfolio 293
12.13.4. Recent Developments 293
12.14. Raindance Technologies Inc. 294
12.14.1. Company Overview 294
12.14.2. Raindance Technologies, Inc.; Company Snapshot 294
12.14.3. Product Portfolio 295
12.14.4. Recent Developments 295
?
12.15. Thermo Fisher Scientific Inc. 296
12.15.1. Company Overview 296
12.15.2. Thermo Fisher Scientific Inc. ;Revenue Analysis 296
12.15.3. Product Portfolio 297
12.15.4. Recent Developments 297
13. Related Reports 298

?